Cardiophrenic Lymph Node Metastasis of Ovarian High-grade Serous Carcinoma Showing Wild-type p53 Immunostaining Pattern and Aberrant CD56 Expression

Int J Surg Pathol. 2021 Dec;29(8):864-869. doi: 10.1177/10668969211006194. Epub 2021 Mar 25.

Abstract

Patterns of p53 immunostaining are used as a surrogate marker for tumor protein 53 (TP53) mutations in the diagnosis of ovarian high-grade serous carcinoma (HGSC). We present a rare case of ovarian HGSC that metastasized to the diaphragm and cardiophrenic lymph nodes and showed the immunostaining pattern of wild-type p53 and aberrant neural cell adhesion molecule (CD56) expression. A 63-year-old woman developed multifocal metastases in the diaphragmatic pleura and cardiophrenic lymph nodes. Because she had a history of ovarian HGSC and pulmonary adenocarcinoma, we considered the possibility that the metastatic carcinoma was of either ovarian or pulmonary origin. Immunostaining revealed that the tumor cells were negative for thyroid transcription factor 1 but positive for Wilms tumor 1. The tumor additionally exhibited strong membranous CD56 expression and patchy p53 expression, both of which were inconsistent with the characteristics of ovarian HGSC. However, targeted sequencing analysis revealed that the tumor harbored a pathogenic mutation at the splice acceptor site of TP53 intron 9 (c.994-1G>C).

Keywords: TP53; cardiophrenic lymph node; high-grade serous carcinoma; immunohistochemistry; ovary; p53; splice site mutation.

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Biomarkers, Tumor / metabolism
  • CD56 Antigen / analysis
  • CD56 Antigen / metabolism
  • Cystadenocarcinoma, Serous / diagnosis*
  • Cystadenocarcinoma, Serous / secondary
  • Female
  • Humans
  • Lymph Nodes / pathology*
  • Lymphatic Metastasis / diagnosis*
  • Lymphatic Metastasis / pathology
  • Middle Aged
  • Neoplasm Grading
  • Ovarian Neoplasms / diagnosis*
  • Ovarian Neoplasms / pathology
  • Tumor Suppressor Protein p53 / analysis
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Biomarkers, Tumor
  • CD56 Antigen
  • NCAM1 protein, human
  • TP53 protein, human
  • Tumor Suppressor Protein p53